Correlation Between Maxigen Biotech and SciVision Biotech
Can any of the company-specific risk be diversified away by investing in both Maxigen Biotech and SciVision Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maxigen Biotech and SciVision Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maxigen Biotech and SciVision Biotech, you can compare the effects of market volatilities on Maxigen Biotech and SciVision Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maxigen Biotech with a short position of SciVision Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maxigen Biotech and SciVision Biotech.
Diversification Opportunities for Maxigen Biotech and SciVision Biotech
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Maxigen and SciVision is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Maxigen Biotech and SciVision Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SciVision Biotech and Maxigen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maxigen Biotech are associated (or correlated) with SciVision Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SciVision Biotech has no effect on the direction of Maxigen Biotech i.e., Maxigen Biotech and SciVision Biotech go up and down completely randomly.
Pair Corralation between Maxigen Biotech and SciVision Biotech
Assuming the 90 days trading horizon Maxigen Biotech is expected to under-perform the SciVision Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Maxigen Biotech is 1.29 times less risky than SciVision Biotech. The stock trades about -0.02 of its potential returns per unit of risk. The SciVision Biotech is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 7,250 in SciVision Biotech on September 2, 2024 and sell it today you would earn a total of 1,920 from holding SciVision Biotech or generate 26.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.73% |
| Values | Daily Returns |
Maxigen Biotech vs. SciVision Biotech
Performance |
| Timeline |
| Maxigen Biotech |
| SciVision Biotech |
Maxigen Biotech and SciVision Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Maxigen Biotech and SciVision Biotech
The main advantage of trading using opposite Maxigen Biotech and SciVision Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maxigen Biotech position performs unexpectedly, SciVision Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SciVision Biotech will offset losses from the drop in SciVision Biotech's long position.| Maxigen Biotech vs. Phytohealth Corp | Maxigen Biotech vs. Orient Pharma Co | Maxigen Biotech vs. Yung Zip Chemical |
| SciVision Biotech vs. Maxigen Biotech | SciVision Biotech vs. Chunghwa Chemical Synthesis | SciVision Biotech vs. Sinphar Pharmaceutical Co | SciVision Biotech vs. ScinoPharm Taiwan |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |